Novel Polymorphic Forms of (4--2-Methylphenyl)Carbonyl]Amino}-3-Methylphenyl)Acetic Acid
OwnerSarah Vallanceinventor
Life of this patent
Estimating the term…
Abstract
Polymorphic forms 1 and 2 of (4-{[(5-{[(3-chlorophenyl)methyl]oxy}-2-methylphenyl)carbonyl]amino}-3-methylphenyl)acetic acid, pharmaceutical compositions comprising such polymorphs and the use of such polymorphs in medicine.
Claims24
A polymorphic form of (4-{[(5-{[(3-chlorophenyl)methyl]oxy}-2-methylphenyl)carbonyl]amino}-3-methylphenyl) acetic acid (Form 1) characterised in that it provides an X-ray powder diffraction (XRPD) diffractogram comprising the following peaks:
- Diffraction
- Lattice
- angle
- spacing
- (°2θ)
- (Å)
- 18.2
- 4.9
- 25.5
- 3.5
(canceled)
(canceled)
A polymorphic form of (4-{[(5-{[(3-chlorophenyl)methyl]oxy}-2-methylphenyl)carbonyl]amino}-3-methylphenyl)acetic acid (Form 2) characterised in that it provides an X-ray powder diffraction (XRPD) diffractogram comprising the following peaks:
- Diffraction
- Lattice
- angle
- spacing
- (°2θ)
- (Å)
- 17.2
- 5.1
- 21.6
- 4.1
(canceled)
(canceled)
The method according to claim, 13 wherein the condition is pain.
Dependencies are inferred from the claim text.